ADX102

ADX102 Uses, Dosage, Side Effects, Food Interaction and all others data.

ADX102 (previously ADX 102 or NS-2) is a small molecule inhibitor being developed by Aldeyra Therapeutics investigated against dry eye disease, allergic conjunctivitis, noninfectious anterior uveitis, and Sjögren-Larsson syndrome. NS-2 has orphan drug status due to it being investigated for treatment of Sjogren-Larsson syndrome.

Trade Name ADX102
Generic Reproxalap
Reproxalap Other Names ADX 102, ADX102, ALD-102, NS-2, Reproxalap
Type
Formula C12H13ClN2O
Weight Average: 236.7
Monoisotopic: 236.0716407
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
ADX102
ADX102

How ADX102 works

ADX102 inhibits Reactive Aldehyde Species (RASP) and is being investigated against dry eye disease, allergic conjunctivitis, noninfectious anterior uveitis, and Sjögren-Larsson syndrome.

Innovators Monograph

You find simplified version here ADX102

*** Taking medicines without doctor's advice can cause long-term problems.
Share